Modalis Therapeutics Corporation [4883.T]
TOKYO, Jun 26 (Pulse News Wire) – Modalis Therapeutics Corporation (4883.T) confirmed the completion of the issuance of its second unsecured bond, totaling June 26, 2026 yen, which was decided upon during a board meeting held on May 27, 2026. The bonds, designated as private placement bonds (), were allotted to EVO FUND. Key details of the bond issue include: - Total amount: June 26, 2026 yen (subject to adjustments based on exercise of subscription rights up to June 12, 2026) - Individual bond amount: ¥100,000 per bond - Interest rate: 0.0% annually - Issue price: Par value of ¥100,000 per bond - Redemption price: Par value of ¥100,000 per bond - Payment date: June 26, 2026 - Redemption date: March 15, 2027 - Repayment method: Full repayment at maturity Additionally, the company outlined various conditions under which early redemption could be requested by bondholders, including scenarios involving changes in stock prices, significant corporate actions, and regulatory designations affecting the company's shares.
🟡 Confidence: Standard AI-translated content.